CRYSTAL ALLEN: Open Payments
NPI 1316598717 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 49 payments from 13 companies in 2025. Trend: 2023 $27 · 2024 $247 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 4 | $192 |
| Corium, LLC | 9 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $156 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
| Alkermes, Inc. | 5 | $116 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| ABBVIE INC. | 3 | $55 |
| Almatica Pharma LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, Azstarys, CAPLYTA, FANAPT, INGREZZA, SPRAVATO, ARISTADA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
